Annika Åstrand

771 total citations
29 papers, 549 citations indexed

About

Annika Åstrand is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Immunology. According to data from OpenAlex, Annika Åstrand has authored 29 papers receiving a total of 549 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 10 papers in Molecular Biology and 8 papers in Immunology. Recurrent topics in Annika Åstrand's work include Cystic Fibrosis Research Advances (8 papers), Hair Growth and Disorders (5 papers) and Dermatology and Skin Diseases (5 papers). Annika Åstrand is often cited by papers focused on Cystic Fibrosis Research Advances (8 papers), Hair Growth and Disorders (5 papers) and Dermatology and Skin Diseases (5 papers). Annika Åstrand collaborates with scholars based in Sweden, United Kingdom and United States. Annika Åstrand's co-authors include Annika Borde, Mohammad Bohlooly‐Y, David Morgan, Jan Törnell, Claes Ohlsson, Margit Mahlapuu, Harriet Andersén, James Root, Robert Tarran and Edvin Johansson and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Biochemical and Biophysical Research Communications.

In The Last Decade

Annika Åstrand

29 papers receiving 538 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Annika Åstrand Sweden 14 167 142 115 106 88 29 549
William Antônio Gonçalves Brazil 10 129 0.8× 61 0.4× 66 0.6× 22 0.2× 65 0.7× 19 426
Qingfeng Tao China 12 168 1.0× 133 0.9× 76 0.7× 31 0.3× 55 0.6× 27 459
Naglaa A. Ahmed Egypt 12 97 0.6× 85 0.6× 149 1.3× 10 0.1× 35 0.4× 21 444
Niall Wilson United Kingdom 10 96 0.6× 71 0.5× 325 2.8× 19 0.2× 44 0.5× 23 634
Evelyn E. Vanderveen United States 10 64 0.4× 104 0.7× 147 1.3× 11 0.1× 59 0.7× 14 512
Tetsuya Moriue Japan 15 140 0.8× 16 0.1× 301 2.6× 17 0.2× 90 1.0× 37 597
Bing Zhu China 14 217 1.3× 106 0.7× 37 0.3× 23 0.2× 52 0.6× 47 553
S.K. Goolamali United Kingdom 11 48 0.3× 41 0.3× 115 1.0× 16 0.2× 20 0.2× 37 480
Bishao Sun China 11 148 0.9× 70 0.5× 5 0.0× 38 0.4× 25 0.3× 28 443
Jiarui Fang China 7 303 1.8× 23 0.2× 12 0.1× 17 0.2× 31 0.4× 9 590

Countries citing papers authored by Annika Åstrand

Since Specialization
Citations

This map shows the geographic impact of Annika Åstrand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annika Åstrand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annika Åstrand more than expected).

Fields of papers citing papers by Annika Åstrand

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annika Åstrand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annika Åstrand. The network helps show where Annika Åstrand may publish in the future.

Co-authorship network of co-authors of Annika Åstrand

This figure shows the co-authorship network connecting the top 25 collaborators of Annika Åstrand. A scholar is included among the top collaborators of Annika Åstrand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annika Åstrand. Annika Åstrand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Åstrand, Annika, Johan Mattsson, Komal Agrawal, et al.. (2024). A comparative study of blood cell count in four automated hematology analyzers: An evaluation of the impact of preanalytical factors. PLoS ONE. 19(5). e0301845–e0301845. 2 indexed citations
2.
Lai, Kefang, Dejun Sun, Ranran Dai, et al.. (2024). Benralizumab efficacy and safety in severe asthma: A randomized trial in Asia. Respiratory Medicine. 229. 107611–107611. 5 indexed citations
3.
Mattsson, Johan, Elisabeth Israelsson, Karin Björhall, et al.. (2023). Selective Janus Kinase 1 Inhibition Resolves Inflammation and Restores Hair Growth Offering a Viable Treatment Option for Alopecia Areata. SHILAP Revista de lepidopterología. 3(3). e209–e209. 5 indexed citations
4.
Åstrand, Annika, et al.. (2023). Effect of COVID-19 on Bronchiectasis Exacerbation Rates: A Retrospective U.S. Insurance Claims Study. Annals of the American Thoracic Society. 21(2). 261–270. 8 indexed citations
5.
Ripa, Lena, Jenny Sandmark, Glyn A. Hughes, et al.. (2023). Selective and Bioavailable HDAC6 2-(Difluoromethyl)-1,3,4-oxadiazole Substrate Inhibitors and Modeling of Their Bioactivation Mechanism. Journal of Medicinal Chemistry. 66(20). 14188–14207. 21 indexed citations
6.
Åstrand, Annika, Emily Falk Libby, Ren‐Jay Shei, et al.. (2022). Preclinical evaluation of the epithelial sodium channel inhibitor AZD5634 and implications on human translation. American Journal of Physiology-Lung Cellular and Molecular Physiology. 323(5). L536–L547. 3 indexed citations
7.
Chen, Yifei, Florian Förster, Markus Dagnell, et al.. (2022). Redox regulation of PTPN22 affects the severity of T-cell-dependent autoimmune inflammation. eLife. 11. 17 indexed citations
8.
Nichols, Ben, Fiona Moffat, Umer Zeeshan Ijaz, et al.. (2022). Stratification of alopecia areata reveals involvement of CD4 T cell populations and altered faecal microbiota. Clinical & Experimental Immunology. 210(2). 175–186. 5 indexed citations
9.
Åstrand, Annika, Scott H. Donaldson, Raolat M. Abdulai, et al.. (2022). AZD5634, an inhaled ENaC inhibitor, in healthy subjects and patients with cystic fibrosis. Journal of Cystic Fibrosis. 21(4). 684–690. 8 indexed citations
10.
Klymiuk, Nikolai, Andrea Bähr, Robert Tarran, et al.. (2021). New generation ENaC inhibitors detach cystic fibrosis airway mucus bundles via sodium/hydrogen exchanger inhibition. European Journal of Pharmacology. 904. 174123–174123. 4 indexed citations
11.
Woodall, Maximillian, et al.. (2021). A modified fluorescent sensor for reporting glucose concentration in the airway lumen. PLoS ONE. 16(7). e0254248–e0254248. 2 indexed citations
12.
McDonald, Elizabeth S., Fiona Moffat, Madhura Castelino, et al.. (2019). Alopecia areata is characterized by dysregulation in systemic type 17 and type 2 cytokines, which may contribute to disease‐associated psychological morbidity. British Journal of Dermatology. 182(1). 130–137. 70 indexed citations
13.
Åstrand, Annika, Marta Bertolini, Alfredo Rossi, et al.. (2019). Alopecia areata patients show deficiency of FOXP3+CD39+ T regulatory cells and clonotypic restriction of Treg TCRβ-chain, which highlights the immunopathological aspect of the disease. PLoS ONE. 14(7). e0210308–e0210308. 34 indexed citations
14.
Arike, Liisa, Ana M. Rodríguez‐Piñeiro, Beatriz Martínez‐Abad, et al.. (2018). Attached stratified mucus separates bacteria from the epithelial cells in COPD lungs. JCI Insight. 3(17). 37 indexed citations
15.
Skogberg, Gabriel, Sonya Jackson, & Annika Åstrand. (2017). Mechanisms of tolerance and potential therapeutic interventions in Alopecia Areata. Pharmacology & Therapeutics. 179. 102–110. 13 indexed citations
16.
Kettle, Jason G., Annika Åstrand, Matthew C. Catley, et al.. (2016). Inhibitors of JAK-family kinases: an update on the patent literature 2013-2015, part 2. Expert Opinion on Therapeutic Patents. 27(2). 145–161. 14 indexed citations
17.
Giordanetto, Fabrizio, Andreas Wållberg, Laurent Knerr, et al.. (2012). Discovery of N-[[1-[2-(tert-butylcarbamoylamino)ethyl]-4-(hydroxymethyl)-4-piperidyl]methyl]-3,5-dichloro-benzamide as a selective T-type calcium channel (Cav3.2) inhibitor. Bioorganic & Medicinal Chemistry Letters. 23(1). 119–124. 4 indexed citations
18.
Giordanetto, Fabrizio, Laurent Knerr, Nidhal Selmi, et al.. (2011). Discovery of N-(1-adamantyl)-2-(4-alkylpiperazin-1-yl)acetamide derivatives as T-type calcium channel (Cav3.2) inhibitors. Bioorganic & Medicinal Chemistry Letters. 21(18). 5557–5561. 5 indexed citations
19.
Stridh, S., Dontscho Kerjaschki, Yun Chen, et al.. (2010). Angiotensin converting enzyme inhibition blocks interstitial hyaluronan dissipation in the neonatal rat kidney via hyaluronan synthase 2 and hyaluronidase 1. Matrix Biology. 30(1). 62–69. 7 indexed citations
20.
Åstrand, Annika, Mohammad Bohlooly‐Y, Margit Mahlapuu, et al.. (2004). Mice lacking melanin-concentrating hormone receptor 1 demonstrate increased heart rate associated with altered autonomic activity. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 287(4). R749–R758. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026